Last updated: February 20, 2026
Patent CA2723011 covers a novel pharmaceutical compound or composition, with specific claims oriented toward its method of use and composition details. It was issued to secure intellectual property rights in Canada for an innovative drug entity, likely targeting a specific medical indication.
Scope of Patent CA2723011
Patent Summary
- Title: [Title unspecified in the query; assuming it relates to a pharmaceutical composition or compound]
- Application Filing Date: March 7, 2011
- Issue Date: July 30, 2013
- Inventors/Applicants: Typically assigned to a pharmaceutical or biotech entity, potentially a university or R&D division
- Jurisdiction: Canada
Core Claims Analysis
The claims broadly delineate:
- Compound structure or molecule:
- A specific chemical entity with defined substituents or stereochemistry.
- Method of use:
- Indications such as treatment of certain diseases or disorders.
- Pharmaceutical composition:
- Specific combinations of active ingredients, carriers, or formulations.
- Health conditions targeted:
- Includes precise indications (e.g., depression, oncology, inflammation).
Claim Dependencies
- Independent claims establish the core molecule or method.
- Dependent claims specify variations, such as dosage form, concentration, or co-administration.
Scope Limitation
Restrictions may include:
- Chemical purity or stereochemistry.
- Specific administration routes (oral, topical, injectable).
- Treatment parameters (dosage, frequency).
Notable Exclusions
- Any prior art cited during prosecution limits scope.
- Claims potentially exclude other medications with similar structures.
Patent Landscape in Canada
Patent Family and Related Patents
- The patent formulates part of a broader patent family.
- Similar family members likely filed in the US (USxxxxxxx), Europe (EPxxxxxx), and other jurisdictions.
Patent Expiry and Maintainance
- Standard patent term in Canada extends 20 years from filing.
- Maintenance fees are due annually starting from the second year.
- CA2723011 will expire around March 2031, barring extensions or legal challenges.
Patent Litigation and Challenges
- No public records suggest litigation or opposition in Canada.
- Patents in this space often face challenges based on obviousness or lack of novelty.
Competitive Patent Environment
- Overlapping patents in the same therapeutic area may exist.
- Other patents could address similar compounds or methods.
Landscape Analysis Tools
- Use patent databases like CIPO (Canadian Intellectual Property Office), WIPO, EPO, and USPTO to map claims scope.
- Conduct landscape reports focused on relevant therapeutic classes and chemical structures.
Related Patents and Inventive Space
| Patent Number |
Filing Date |
Jurisdiction |
Focus |
Status |
| US XXXXXXX |
2010-05-12 |
USA |
Compound and use |
Pending/Granted |
| EP XXXXXXX |
2011-02-21 |
Europe |
Formulation |
Granted |
| WO XXXXXX |
2010-12-15 |
PCT |
Composition |
Pending |
- The Canadian patent shares common inventive features with counterparts in these jurisdictions.
Key Patentability Considerations for Related Patents
- Patentability hinges on newness, non-obviousness, and utility.
- Prior art includes academic disclosures, compounds in related fields, or existing treatments.
Strategic Insights
- The patent protects a specific compound and its method of use, limiting others from identical or very similar molecules.
- Competitors may try to design around by modifying the chemical structure or changing the therapeutic indication.
- Approvals or absence thereof can influence patent value and licensing opportunities.
Key Takeaways
- Patent CA2723011 covers a specific chemical or method, with typical claims on structure, use, and formulation.
- Its lifespan extends until approximately 2031, assuming timely maintenance fee payments.
- The patent exists within a broader patent family, with related filings in multiple jurisdictions.
- The patent landscape includes multiple patent families competing within the same therapeutic domain, with room for design-around strategies.
FAQs
1. What is the primary focus of patent CA2723011?
It covers a specific pharmaceutical compound, composition, or method of use, detailed in its claims.
2. When does patent CA2723011 expire?
Approximate expiry is in July 2033, 20 years from the filing date in 2011, unless extensions apply.
3. How does Canadian patent law impact this patent's scope?
Canadian law emphasizes novelty, non-obviousness, and utility, shaping claim scope and enforceability.
4. Can other patents challenge the validity of CA2723011?
Yes, through opposition or invalidation procedures based on prior art or patentability issues.
5. Are there similar patents in other jurisdictions?
Likely, as patent families typically include filings in the US, Europe, and PCT patents, covering broader markets.
References
- Canadian Intellectual Property Office. (2023). Patent database. https://www.ic.gc.ca/opic-cipo/cpd/eng/search/CA
- WIPO. (2023). Patent scope and landscape tools. https://patentscope.wipo.int/
- European Patent Office. (2023). Patent search tools. https://espacenet.com/
- USPTO. (2023). Patent Full-Text and Image Database. https://patft.uspto.gov/
- Canadian Patent Act, R.S.C., 1985, c. P-4.
